Findings hold promise for developing regenerative therapies for spinal cord injuries and diseases such as multiple sclerosis
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of UC Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin — a fatty, insulating sheath essential to normal neural conduction.
“Our findings represent an important conceptual advance in stem cell research,” said Wenbin Deng, principal investigator of the study and associate professor at the UC Davis Department of Biochemistry and Molecular Medicine. “We have bioengineered the first generation of myelin-producing cells with superior regenerative capacity.”
The brain is made up predominantly of two cell types: neurons and glial cells. Neurons are regarded as responsible for thought and sensation. Glial cells surround, support and communicate with neurons, helping neurons process and transmit information using electrical and chemical signals. One type of glial cell — the oligodendrocyte — produces a sheath called myelin that provides support and insulation to neurons. Myelin, which has been compared to insulation around electrical wires that helps to prevent short circuits, is essential for normal neural conduction and brain function; well-recognized conditions involving defective myelin development or myelin loss include multiple sclerosis and leukodystrophies.
In this study, the UC Davis team first developed a novel protocol to efficiently induce embryonic stem cells (ESCs) to differentiate into oligodendroglial progenitor cells (OPCs), early cells that normally develop into oligodendrocytes. Although this has been successfully done by other researchers, the UC Davis method results in a purer population of OPCs, according to Deng, with fewer other cell types arising from their technique.
They next compared electrophysiological properties of the derived OPCs to naturally occurring OPCs. They found that unlike natural OPCs, the ESC-derived OPCs lacked sodium ion channels in their cell membranes, making them unable to generate spikes when electrically stimulated. Using a technique called viral transduction, they then introduced DNA that codes for sodium channels into the ESC-derived OPCs. These OPCs then expressed ion channels in their cells and developed the ability to generate spikes.
According to Deng, this is the first time that scientists have successfully generated OPCs with so-called spiking properties. This achievement allowed them to compare the capabilities of spiking cells to non-spiking cells.
In cell culture, they found that only spiking OPCs received electrical input from neurons, and they showed superior capability to mature into oligodendrocytes.
They also transplanted spiking and non-spiking OPCs into the spinal cord and brains of mice that are genetically unable to produce myelin. Both types of OPCs had the capability to mature into oligo-dendrocytes and produce myelin, but those from spiking OPCs produced longer and thicker myelin sheaths around axons.
“We actually developed ‘super cells’ with an even greater capacity to spike than natural cells,” Deng said. “This appears to give them an edge for maturing into oligodendrocytes and producing better myelin.”
It is well known that adult human neural tissue has a poor capacity to regenerate naturally. Although early cells such as OPCs are present, they do not regenerate tissue very effectively when disease or injury strikes.
Deng believes that replacing glial cells with the enhanced spiking OPCs to treat neural injuries and diseases has the potential to be a better strategy than replacing neurons, which tend to be more problematic to work with. Providing the proper structure and environment for neurons to live may be the best approach to regenerate healthy neural tissue. He also notes that many diverse conditions that have not traditionally been considered to be myelin-related diseases – including schizophrenia, epilepsy and amyotrophic lateral sclerosis (ALS) – actually are now recognized to involve defective myelin.
The Latest on: Stem cell technology
- Stem Cell Antibody Market Analysis and In-depth Research on Market Size, Trends, Emerging Growth Factors and Regional Forecasts to 2025 on December 13, 2018 at 2:32 pm
The Stem Cell Antibody Market report analyses the competitive landscape read of the business. The Stem Cell Antibody report includes development plans and policies at the side of producing processes. ... […]
- Biological Industries USA Announces Call for Applications for 2019 Stem Cell Research Awards on December 13, 2018 at 12:39 pm
Please purchase a subscription to continue reading. A subscription is required to continue reading. Thank you for reading PressofAtlanticCity.com. If you are a current subscriber you are granted an al... […]
- New technology detects firing of nerve cells on December 13, 2018 at 11:39 am
Technology that can detect when nerve cells fire, which can be used to observe nerve activity in the eye as well as other light-accessible parts of the body, has been created by researchers at Stanfor... […]
- Companies tracking mutations in cancer cells can provide a key to unlocking better therapies on December 13, 2018 at 9:02 am
Earlier this month, research using technology developed by the startup Mission Bio helped identify cellular mutations in acute myeloid leukemia cancer cells that could be indicators of potential ... […]
- Researchers design technology that sees nerve cells fire on December 12, 2018 at 11:12 pm
Signal from optical imaging (top) matches the signal from an electrode array (bottom). Credit: Daniel Palanker, Ph.D., Stanford University. Researchers at Stanford University, Palo Alto ... […]
- Researchers create noninvasive technology that detects when nerve cells fire on December 12, 2018 at 11:08 pm
Researchers at Stanford University, Palo Alto, California, have created a noninvasive technology that detects when nerve cells fire based on changes in shape. The method could be used to observe nerve ... […]
- Synthetic Stem Cell market size worth $37 million by 2028 on December 12, 2018 at 4:57 am
North America is estimated to account for the largest share of the market in 2023. North America is the pioneer of synthetic stem cell technology. Also, North America leads in the R&D of stem cell the... […]
- New Technology for Profiling Myeloma Cells on December 11, 2018 at 2:24 pm
Newswise — Cancer arises when cells lose control. Deciphering the “blueprint” of cancer cells – outlining how cancer cells hijack specific pathways for uncontrolled proliferation – will lead to more e... […]
- Innovations in Stem Cells for Regenerative Medicine on December 11, 2018 at 11:33 am
We can make changes at the molecular level and create ‘designer’ cells. A number of other technologies are becoming important as well. Omics analysis, such as single-cell RNA sequencing, allows us to ... […]
- New light-based technology reveals how cells communicate in human disease on December 11, 2018 at 6:43 am
An oscillating light on a sensor helps scientists see individual cells under a microscope and how they behave. Credit: University of York Scientists at the University of York have developed a new ... […]
via Google News and Bing News